Chromosomal changes in aggressive breast cancers with basal-like features

Cancer Genetics and Cytogenetics

Volumn 193, Issue 1, 2009, Pages 29-37

  Yu, Wayne ^a   Kanaan, Yasmine ^b   Baed, Young Kyung ^b   Gabrielson, Edward ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE B BETA; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR JUND; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER GRADING; CHROMOSOME 12Q; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 19P; CHROMOSOME 19Q; CHROMOSOME 1Q; CHROMOSOME 4Q; CHROMOSOME 5Q; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CHROMOSOME NUMBER; CHROMOSOME REARRANGEMENT; CHROMOSOME XQ; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENE LOSS; GENETIC GAIN; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA FINGERPRINTING; BREAST TUMOR; CHROMOSOME DELETION; DISEASE COURSE; DNA MICROARRAY; FEMALE; GENE DOSAGE; GENETICS; ONCOGENE; PATHOLOGY;

BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE PROGRESSION; FEMALE; GENE DOSAGE; HUMANS; IMMUNOHISTOCHEMISTRY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; TUMOR MARKERS, BIOLOGICAL;

EID: 67651083565     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.03.017     Document Type: Article

References (34)

1. Murad T.M. A proposed histochemical and electron microscopic classification of human breast cancer according to cell of origin. Cancer 27 (1971) 288-299
2. Dairkee S.H., Ljung B.M., Smith H., and Hackett A. Immunolocalization of a human basal epithelium specific keratin in benign and malignant breast disease. Breast Cancer Res Treat 10 (1987) 11-20
3. Fan C., Oh D.S., Wessels L., Weigelt B., Nuyten D.S., Nobel A.B., van't Veer LJ., and Perou C.M. Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355 (2006) 560-569
4. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., Pollack J.R., Ross D.T., Johnsen H., Akslen L.A., Fluge O., Pergamenschikov A., Williams C., Zhu S.X., Lonning P.E., Borresen-Dale A.L., Brown PO., and Botstein D. Molecular portraits of human breast tumours. Nature 406 (2000) 747-752
5. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Thorsen T., Quist H., Matese J.C., Brown P.O., Botstein D., Eystein Lonning P., and Borresen-Dale A.L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98 (2001) 10869-10874
6. Fadare O., and Tavassoli F.A. The phenotypic spectrum of basal-like breast cancers: a critical appraisal. Adv Anat Pathol 14 (2007) 358-373
7. Livasy C.A., Karaca G., Nanda R., Tretiakova M.S., Olopade O.I., Moore DT., and Perou C.M. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol 19 (2006) 264-271
8. Cheang M.C., Voduc D., Bajdik C., Leung S., McKinney S., Chia S.K., and Perou CM Nielsen T.O. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 14 (2008) 1368-1376
9. Fulford L.G., Easton D.F., Reis-Filho J.S., Sofronis A., Gillett C.E., Lakhani SR., and Hanby A. Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast. Histopathology 49 (2006) 22-34
10. Kreike B., van Kouwenhove M., Horlings H., Weigelt B., Bartelink H., and Van de Vijver M.J. Gene expression profiling and histopathological characterization of triple negative/basal-like breast carcinomas. Breast Cancer Res 9 (2007) R65
11. Rakha E.A., Putti T.C., Abd El-Rehim D.M., Paish C., Green A.R., Powe D.G., Lee A.H., Robertson JF., and Ellis I.O. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol 208 (2006) 495-506
12. Rakha E.A., El-Sayed M.E., Green A.R., Paish E.C., and Lee AH Ellis I.O. Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression. Histopathology 50 (2007) 434-438
13. Adelaide J., Finetti P., Bekhouche I., Repellini L., Geneix J., Sircoulomb F., Charafe-Jauffret E., Cervera N., Desplans J., Parzy D., Schoenmakers E., Viens P., Jacquemier J., Birnbaum D., Bertucci F., and Chaffanet M. Integrated profiling of basal and luminal breast cancers. Cancer Res 67 (2007) 11565-11575
14. Bergamaschi A., Kim Y.H., Wang P., Sorlie T., Hernandez-Boussard T., Lonning P.E., Tibshirani R., Borresen-Dale AL., and Pollack J.R. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer 45 (2006) 1033-1040
15. Chin K., DeVries S., Fridlyand J., Spellman P.T., Roydasgupta R., Kuo W.L., Lapuk A., Neve R.M., Qian Z., Ryder T., Chen F., Feiler H., Tokuyasu T., Kingsley C., Dairkee S., Meng Z., Chew K., Pinkel D., Jain A., Ljung B.M., Esserman L., Albertson D.G., Waldman F.M., and Gray J.W. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10 (2006) 529-541
16. Jones C., Ford E., Gillett C., Ryder K., Merrett S., Reis-Filho J.S., Fulford L.G., Hanby A., and Lakhani S.R. Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes. Clin Cancer Res 10 (2004) 5988-5997
17. Naylor T.L., Greshock J., Wang Y., Colligon T., Yu Q.C., Clemmer V., Zaks TZ., and Weber B.L. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Breast Cancer Res 7 (2005) R1186-R1198
18. Wang Z.C., Lin M., Wei L.J., Li C., Miron A., Lodeiro G., Harris L., Ramaswamy S., Tanenbaum D.M., Meyerson M., Iglehart J.D., and Richardson A. Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers. Cancer Res 64 (2004) 64-71
19. Bellacosa A., de Feo D., Godwin A.K., Bell D.W., Cheng J.Q., Altomare D.A., Wan M., Dubeau L., Scambia G., Masciullo V., Ferrandina G., Benedetti Panici P., Mancuso S., Neri G., and Testa J.R. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer 64 (1995) 280-285
20. Simon R., Panussis S., Maurer R., Spichtin H., Glatz K., Tapia C., Mirlacher M., Rufle A., Torhorst J., and Sauter G. KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations. Clin Cancer Res 10 (2004) 178-183
21. Nielsen T.O., Hsu F.D., Jensen K., Cheang M., Karaca G., Hu Z., Hernandez-Boussard T., Livasy C., Cowan D., Dressler L., Akslen L.A., Ragaz J., Gown A.M., Gilks C.B., van de Rijn M., and Perou C.M. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10 (2004) 5367-5374
22. Puputti M., Tynninen O., Sihto H., Blom T., Maenpaa H., Isola J., Paetau A., Joensuu H., and Nupponen N.N. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas. Mol Cancer Res 4 (2006) 927-934
23. Joensuu H., Puputti M., Sihto H., Tynninen O., and Nupponen N.N. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme. J Pathol 207 (2005) 224-231
24. McIntyre A., Summersgill B., Grygalewicz B., Gillis A.J., Stoop J., van Gurp R.J., Dennis N., Fisher C., Huddart R., Cooper C., Clark J., Oosterhuis J.W., Looijenga L.H., and Shipley J. Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults. Cancer Res 65 (2005) 8085-8089
25. Berger I., and Shaul Y. Structure and function of human jun-D. Oncogene 6 (1991) 561-566
26. Ryder K., Lanahan A., Perez-Albuerne E., Nathans D., and jun- D. a third member of the jun gene family. Proc Natl Acad Sci USA 86 (1989) 1500-1503
27. Mariani O., Brennetot C., Coindre J.M., Gruel N., Ganem C., Delattre O., Stern M.H., and Aurias A. JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas. Cancer Cell 11 (2007) 361-374
28. Smith L.M., Wise S.C., Hendricks D.T., Sabichi A.L., Bos T., Reddy P., Brown P.H., and Birrer M.J. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene 18 (1999) 6063-6070
29. Zhang Y., Pu X., Shi M., Chen L., Song Y., Qian L., Yuan G., Zhang H., Yu M., Hu M., Shen B., and Guo N. Critical role of c-Jun overexpression in liver metastasis of human breast cancer xenograft model. BMC Cancer 7 (2007) 145
30. Al-Kuraya K., Schraml P., Torhorst J., Tapia C., Zaharieva B., Novotny H., Spichtin H., Maurer R., Mirlacher M., Kochli O., Zuber M., Dieterich H., Mross F., Wilber K., Simon R., and Sauter G. Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res 64 (2004) 8534-8540
31. Korsching E., Packeisen J., Agelopoulos K., Eisenacher M., Voss R., Isola J., van Diest P.J., Brandt B., Boecker W., and Buerger H. Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis. Lab Invest 82 (2002) 1525-1533
32. Jones C., Foschini M.P., Chaggar R., Lu Y.J., Wells D., Shipley J.M., Eusebi V., and Lakhani S.R. Comparative genomic hybridization analysis of myoepithelial carcinoma of the breast. Lab Invest 80 (2000) 831-836
33. Sjoblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K., Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W., and Velculescu V.E. The consensus coding sequences of human breast and colorectal cancers. Science 314 (2006) 268-274
34. Wood L.D., Parsons D.W., Jones S., Lin J., Sjoblom T., Leary R.J., Shen D., Boca S.M., Barber T., Ptak J., Silliman N., Szabo S., Dezso Z., Ustyanksky V., Nikolskaya T., Nikolsky Y., Karchin R., Wilson P.A., Kaminker J.S., Zhang Z., Croshaw R., Willis J., Dawson D., Shipitsin M., Willson J.K., Sukumar S., Polyak K., Park B.H., Pethiyagoda C.L., Pant P.V., Ballinger D.G., Sparks A.B., Hartigan J., Smith D.R., Suh E., Papadopoulos N., Buckhaults P., Markowitz S.D., Parmigiani G., Kinzler K.W., Velculescu V.E., and Vogelstein B. The genomic landscapes of human breast and colorectal cancers. Science 318 (2007) 1108-1113